Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Iodixanol manufacturers

Filters

None products found

iodixanol

Injection 270 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Manufacturer usually replies in 8 days

iodixanol

Injection 16 g/50 ml, 32 g/100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36808

Established in 2003, this manufacturer operates as a CTD dossier owner and manufacturer, specializing in generics, biological products, vaccines, IVD products, animal health products, and purified herbal products. As a CTD dossier owner and manufacturer, it has registered and distributed products in more than 20 countries and regions worldwide. With a team of 10 to 19 employees, the manufacturer has over 20 years of experience in the industry.

Manufacturer usually replies in 13 days

iodixanol

Vials 320 mg/ml - 50 ml, 100 ml, 270 mg/ml - 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP, PICS
Manufacturer #22656

The company is a pharmaceutical manufacturer engaged in the research, development, production and commercialization of a broad portfolio of pharmaceutical products including contrast media, APIs and a range of medicines used in diagnostic imaging and therapeutic applications, operating with certified manufacturing capabilities and quality systems to develop and supply these pharmaceutical products to domestic and international healthcare markets.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

IODIXANOL Manufacturers

Markets of interest

IODIXANOL is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. The substance is available for sale in the form of a solution for injection, from manufacturers in various countries including Y. The drug is provided by a wide range of IODIXANOL suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading IODIXANOL manufacturers and distributors are based in China.

Licensing and brand names

Under the trade name Visipaque IODIXANOL was first approved for use in both intra-arterial and intravenous radiologic procedures on March 22, 1996. The medication is presently approved in many countries and is available in both generic and trade name versions. One of the most popular branded versions of IODIXANOL is manufactured and supplied by the Chinese pharmaceutical company JINLAN Pharm-Drugs Technology Co., Ltd. Other manufacturing companies and distributors from Argentina, Turkey have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with IODIXANOL as an active ingredient.

Target supply price

The wholesale acquisition cost of Gadavist intravenous solution (604.72 mg/mL) is around $80 for a supply of 7.5 milliliters. The retail price of 550mg / ml solution for injection of 100ml N10 container in Europe reaches 663.45 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the IODIXANOL manufacturers and suppliers that you are looking for. You can also find the dossier status of IODIXANOL and the GMP approvals of the different variants of the medication. The product description of all IODIXANOL suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where IODIXANOL is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.